UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported) February 17, 2009
MEDIFAST,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-23016
|
|
13-3714405
|
(State
or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS
Employer Ident
No.
|
11445
Cronhill Drive, Owing Mills, Maryland
|
|
21117
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code
|
(410)-581-8042
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
7.01 Regulation
FD Disclosure
On
February 17, 2009, Medifast, Inc. (the “Company”) issued a press release in
response to allegations made against the Company on the Internet by an unrelated
third party.
A copy of Medifast’s press release is
attached hereto as Exhibit 99.1 and hereby incorporated by
reference.
Item
9.01 Exhibits
Exhibits
pursuant to Item 7.01
99.1 Press
release issued by Medifast, Inc. on February 17, 2009
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
MEDIFAST,
INC. |
|
|
|
|
|
Dated: February
18, 2009 |
|
|
|
|
|
|
|
|
|
/s/ Michael
S. McDevitt |
|
|
|
Michael
S. McDevitt |
|
|
|
Chief
Executive Officer |
|
|
|
|
|